Palvella Therapeutics, Inc. PVLA
PVLA
Palvella Therapeutics, Inc. ABUS
Arbutus Biopharma Corporation VALN
Valneva SE GHRS
GH Research PLC AVBP
ArriVent BioPharma, Inc. Common Stock GERN
Geron Corporation VIR
Vir Biotechnology, Inc. DNA
Ginkgo Bioworks Holdings, Inc. IOVA
Iovance Biotherapeutics, Inc. AVXL
Anavex Life Sciences Corp.
Palvella Therapeutics, Inc. ABUS
Arbutus Biopharma Corporation VALN
Valneva SE GHRS
GH Research PLC AVBP
ArriVent BioPharma, Inc. Common Stock GERN
Geron Corporation VIR
Vir Biotechnology, Inc. DNA
Ginkgo Bioworks Holdings, Inc. IOVA
Iovance Biotherapeutics, Inc. AVXL
Anavex Life Sciences Corp.
Performance
| Periode | PVLA | ABUS | VALN | GHRS | AVBP | GERN | VIR | DNA | IOVA | AVXL |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 187.51 % | 32.52 % | 35.85 % | 46.38 % | -10.66 % | -12.68 % | -2.29 % | 73.09 % | -35.90 % | -8.55 % |
| YTD | 508.33 % | 32.52 % | 102.33 % | 76.36 % | -32.29 % | -65.56 % | -17.74 % | 32.78 % | -71.12 % | -29.09 % |
| 1Y | 329.41 % | 9.82 % | 60.77 % | 82.35 % | -41.29 % | -69.46 % | -20.05 % | 66.30 % | -78.91 % | 64.41 % |
| 3Y | 329.41 % | 100.92 % | -28.46 % | 39.50 % | -7.00 % | -48.12 % | -72.72 % | -87.71 % | -76.80 % | -27.42 % |
| 5Y | 329.41 % | 54.06 % | -63.84 % | -27.53 % | -7.00 % | -32.24 % | -83.28 % | -96.65 % | -93.91 % | 53.84 % |
| 10Y | 329.41 % | -27.45 % | -63.84 % | -27.53 % | -7.00 % | -64.57 % | -57.35 % | -96.65 % | -63.11 % | 2.99 % |
| Depuis le début | 329.41 % | -30.79 % | -63.84 % | -27.53 % | -7.00 % | -83.08 % | -57.35 % | -96.65 % | -97.95 % | 7.69 % |